

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.75978372 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.75978372 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.65996555 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.65996555 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.63195142 |
| 6 | glyoxylate metabolic process (GO:0046487) | 5.20070854 |
| 7 | behavioral response to nicotine (GO:0035095) | 4.94984317 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.70767150 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.65467733 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.65467733 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.65467733 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.64358824 |
| 13 | lysine catabolic process (GO:0006554) | 4.50382831 |
| 14 | lysine metabolic process (GO:0006553) | 4.50382831 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.50335396 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.49041249 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.45001369 |
| 18 | bile acid biosynthetic process (GO:0006699) | 4.43129789 |
| 19 | kynurenine metabolic process (GO:0070189) | 4.41643647 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 4.40048214 |
| 21 | cysteine metabolic process (GO:0006534) | 4.38601387 |
| 22 | aromatic amino acid family metabolic process (GO:0009072) | 4.28169313 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.14702895 |
| 24 | amino-acid betaine metabolic process (GO:0006577) | 4.14677350 |
| 25 | tyrosine metabolic process (GO:0006570) | 4.07797799 |
| 26 | urea metabolic process (GO:0019627) | 3.99860382 |
| 27 | urea cycle (GO:0000050) | 3.99860382 |
| 28 | alpha-amino acid catabolic process (GO:1901606) | 3.97927635 |
| 29 | glucocorticoid biosynthetic process (GO:0006704) | 3.92045426 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 3.90652483 |
| 31 | valine metabolic process (GO:0006573) | 3.87925159 |
| 32 | bile acid metabolic process (GO:0008206) | 3.86902654 |
| 33 | drug transmembrane transport (GO:0006855) | 3.86666812 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 3.85423979 |
| 35 | branched-chain amino acid catabolic process (GO:0009083) | 3.85077098 |
| 36 | fatty acid beta-oxidation (GO:0006635) | 3.83624492 |
| 37 | cellular amino acid catabolic process (GO:0009063) | 3.79061525 |
| 38 | 2-oxoglutarate metabolic process (GO:0006103) | 3.78653526 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 3.78274911 |
| 40 | ketone body metabolic process (GO:1902224) | 3.76164078 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.74151071 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73713549 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 3.73713549 |
| 44 | macromolecular complex remodeling (GO:0034367) | 3.73713549 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 3.72860948 |
| 46 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.71957894 |
| 47 | protein carboxylation (GO:0018214) | 3.71957894 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 3.70056702 |
| 49 | fatty acid oxidation (GO:0019395) | 3.65999662 |
| 50 | reverse cholesterol transport (GO:0043691) | 3.65599946 |
| 51 | aldehyde catabolic process (GO:0046185) | 3.64976227 |
| 52 | branched-chain amino acid metabolic process (GO:0009081) | 3.62617312 |
| 53 | fatty acid catabolic process (GO:0009062) | 3.59835605 |
| 54 | lipid oxidation (GO:0034440) | 3.59162566 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.57435977 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 3.57292738 |
| 57 | bile acid and bile salt transport (GO:0015721) | 3.56566193 |
| 58 | organic acid catabolic process (GO:0016054) | 3.56255051 |
| 59 | carboxylic acid catabolic process (GO:0046395) | 3.56255051 |
| 60 | coenzyme catabolic process (GO:0009109) | 3.55850962 |
| 61 | acylglycerol homeostasis (GO:0055090) | 3.52620825 |
| 62 | triglyceride homeostasis (GO:0070328) | 3.52620825 |
| 63 | monocarboxylic acid catabolic process (GO:0072329) | 3.51671805 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.51582155 |
| 65 | low-density lipoprotein particle remodeling (GO:0034374) | 3.50351879 |
| 66 | fucose catabolic process (GO:0019317) | 3.46562587 |
| 67 | L-fucose metabolic process (GO:0042354) | 3.46562587 |
| 68 | L-fucose catabolic process (GO:0042355) | 3.46562587 |
| 69 | drug catabolic process (GO:0042737) | 3.45210389 |
| 70 | complement activation, alternative pathway (GO:0006957) | 3.44708603 |
| 71 | sulfation (GO:0051923) | 3.43950287 |
| 72 | regulation of protein activation cascade (GO:2000257) | 3.43132158 |
| 73 | aspartate family amino acid catabolic process (GO:0009068) | 3.41557808 |
| 74 | carnitine metabolic process (GO:0009437) | 3.41302227 |
| 75 | estrogen biosynthetic process (GO:0006703) | 3.40847915 |
| 76 | tricarboxylic acid metabolic process (GO:0072350) | 3.40457472 |
| 77 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.37861336 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.37725220 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.37466912 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 3.36997693 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.36384609 |
| 82 | phospholipid efflux (GO:0033700) | 3.35995670 |
| 83 | amine catabolic process (GO:0009310) | 3.34352725 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 3.34352725 |
| 85 | drug transport (GO:0015893) | 3.34064106 |
| 86 | nonmotile primary cilium assembly (GO:0035058) | 3.32335626 |
| 87 | urate metabolic process (GO:0046415) | 3.30378061 |
| 88 | arginine metabolic process (GO:0006525) | 3.29912184 |
| 89 | glycine metabolic process (GO:0006544) | 3.29441948 |
| 90 | cellular glucuronidation (GO:0052695) | 3.28661475 |
| 91 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.27793519 |
| 92 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.27793519 |
| 93 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.27793519 |
| 94 | response to mercury ion (GO:0046689) | 3.26422387 |
| 95 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.24905136 |
| 96 | androgen biosynthetic process (GO:0006702) | 3.22805671 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.21915100 |
| 98 | ethanol oxidation (GO:0006069) | 3.21415671 |
| 99 | drug metabolic process (GO:0017144) | 3.18027466 |
| 100 | negative regulation of cholesterol transport (GO:0032375) | 3.16143377 |
| 101 | negative regulation of sterol transport (GO:0032372) | 3.16143377 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.15855803 |
| 103 | glutamate metabolic process (GO:0006536) | 3.15649262 |
| 104 | regulation of complement activation (GO:0030449) | 3.15559068 |
| 105 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.13510078 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.11351120 |
| 107 | somite development (GO:0061053) | 3.08907029 |
| 108 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.07423064 |
| 109 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.04710772 |
| 110 | fructose metabolic process (GO:0006000) | 3.04083704 |
| 111 | small molecule catabolic process (GO:0044282) | 3.03723557 |
| 112 | cholesterol efflux (GO:0033344) | 3.02075872 |
| 113 | blood coagulation, intrinsic pathway (GO:0007597) | 3.01306218 |
| 114 | gamma-aminobutyric acid transport (GO:0015812) | 3.00197004 |
| 115 | alkaloid metabolic process (GO:0009820) | 3.00105710 |
| 116 | plasma lipoprotein particle clearance (GO:0034381) | 2.99912718 |
| 117 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.99297218 |
| 118 | exogenous drug catabolic process (GO:0042738) | 2.98912436 |
| 119 | very long-chain fatty acid metabolic process (GO:0000038) | 2.98743391 |
| 120 | limb bud formation (GO:0060174) | 2.92411765 |
| 121 | response to pheromone (GO:0019236) | 2.92208086 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.85248758 |
| 123 | platelet dense granule organization (GO:0060155) | 2.80541992 |
| 124 | epithelial cilium movement (GO:0003351) | 2.79600085 |
| 125 | nucleobase catabolic process (GO:0046113) | 2.74902707 |
| 126 | behavioral response to ethanol (GO:0048149) | 2.74222921 |
| 127 | regulation of gene silencing by RNA (GO:0060966) | 2.70356485 |
| 128 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.70356485 |
| 129 | regulation of gene silencing by miRNA (GO:0060964) | 2.70356485 |
| 130 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.69733454 |
| 131 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.68106273 |
| 132 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.68106273 |
| 133 | NADH dehydrogenase complex assembly (GO:0010257) | 2.68106273 |
| 134 | glucocorticoid metabolic process (GO:0008211) | 2.67948487 |
| 135 | inner ear receptor stereocilium organization (GO:0060122) | 2.67269642 |
| 136 | transmission of nerve impulse (GO:0019226) | 2.63564370 |
| 137 | oxidative demethylation (GO:0070989) | 2.62548982 |
| 138 | kidney morphogenesis (GO:0060993) | 2.61712104 |
| 139 | replication fork processing (GO:0031297) | 2.60782102 |
| 140 | nephron epithelium morphogenesis (GO:0072088) | 2.59944617 |
| 141 | nephron tubule morphogenesis (GO:0072078) | 2.59944617 |
| 142 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.58328764 |
| 143 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.58328764 |
| 144 | C4-dicarboxylate transport (GO:0015740) | 2.57308363 |
| 145 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.55972045 |
| 146 | DNA double-strand break processing (GO:0000729) | 2.55873370 |
| 147 | cornea development in camera-type eye (GO:0061303) | 2.53243556 |
| 148 | presynaptic membrane assembly (GO:0097105) | 2.52995923 |
| 149 | retinal ganglion cell axon guidance (GO:0031290) | 2.51445426 |
| 150 | protein complex biogenesis (GO:0070271) | 2.49833938 |
| 151 | postsynaptic membrane organization (GO:0001941) | 2.48801341 |
| 152 | response to follicle-stimulating hormone (GO:0032354) | 2.47872362 |
| 153 | S-adenosylmethionine metabolic process (GO:0046500) | 2.47319333 |
| 154 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.46597397 |
| 155 | regulation of mesoderm development (GO:2000380) | 2.46144808 |
| 156 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.45078525 |
| 157 | cellular response to gonadotropin stimulus (GO:0071371) | 2.44027061 |
| 158 | neural tube formation (GO:0001841) | 2.43776715 |
| 159 | cilium organization (GO:0044782) | 2.42388392 |
| 160 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.42039416 |
| 161 | detection of light stimulus involved in visual perception (GO:0050908) | 2.42039416 |
| 162 | indole-containing compound metabolic process (GO:0042430) | 2.39599373 |
| 163 | otic vesicle formation (GO:0030916) | 2.38059779 |
| 164 | cilium morphogenesis (GO:0060271) | 2.37648684 |
| 165 | primary amino compound metabolic process (GO:1901160) | 2.37299123 |
| 166 | regulation of hippo signaling (GO:0035330) | 2.36878819 |
| 167 | cilium assembly (GO:0042384) | 2.36213012 |
| 168 | hormone biosynthetic process (GO:0042446) | 2.35513193 |
| 169 | synaptic transmission, cholinergic (GO:0007271) | 2.35212267 |
| 170 | auditory receptor cell stereocilium organization (GO:0060088) | 2.33687909 |
| 171 | atrial cardiac muscle cell action potential (GO:0086014) | 2.33427912 |
| 172 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.31807467 |
| 173 | cellular response to sterol (GO:0036315) | 2.30194262 |
| 174 | neuronal action potential propagation (GO:0019227) | 2.29913062 |
| 175 | ubiquinone metabolic process (GO:0006743) | 2.29247748 |
| 176 | regulation of male gonad development (GO:2000018) | 2.29240942 |
| 177 | cell proliferation in forebrain (GO:0021846) | 2.28967141 |
| 178 | reciprocal meiotic recombination (GO:0007131) | 2.27936442 |
| 179 | reciprocal DNA recombination (GO:0035825) | 2.27936442 |
| 180 | parturition (GO:0007567) | 2.27529250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.90271196 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20322255 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.40734133 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.17023287 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.73822278 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72538872 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.55503883 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.87740441 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.73053733 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.66005527 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.17721086 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 3.13595918 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.01183599 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.96813714 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.67472110 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.58435486 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.49269243 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.48965680 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.42535864 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.39416776 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.34880483 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.32967065 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.31597137 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.28167178 |
| 25 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25497342 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.21042845 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.19559491 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.18634909 |
| 29 | EWS_26573619_Chip-Seq_HEK293_Human | 2.16326700 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15191197 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 2.12650326 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10012694 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.05948027 |
| 34 | P300_19829295_ChIP-Seq_ESCs_Human | 2.05496154 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02040416 |
| 36 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92845272 |
| 37 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91231708 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88080114 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83172192 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75827598 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75796711 |
| 42 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.70893477 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.69502478 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.65604350 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.65416318 |
| 46 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.61321725 |
| 47 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59371302 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58947355 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57777596 |
| 50 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57402955 |
| 51 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.57402955 |
| 52 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.57245559 |
| 53 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.56434845 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.53107677 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.51517194 |
| 56 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51509110 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.50788719 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49545167 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49192902 |
| 60 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48648208 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.48394878 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48221516 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.46186852 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45811682 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45397471 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45310532 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43946386 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43086574 |
| 69 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42497871 |
| 70 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.42432688 |
| 71 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42098409 |
| 72 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39978670 |
| 73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.38289207 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36719915 |
| 75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36456655 |
| 76 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.36125745 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34664239 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33951852 |
| 79 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33382032 |
| 80 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33336243 |
| 81 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32678233 |
| 82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.32166250 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31868648 |
| 84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31329794 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30418269 |
| 86 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.29144167 |
| 87 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28609603 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28518683 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27825581 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26190037 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26190037 |
| 92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25769383 |
| 93 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25769383 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25217548 |
| 95 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.25146447 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23321625 |
| 97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22097676 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21609846 |
| 99 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.20995595 |
| 100 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20464104 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20047001 |
| 102 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.19838989 |
| 103 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19714494 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19677136 |
| 105 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19648256 |
| 106 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19252425 |
| 107 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.18579951 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17810636 |
| 109 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.17518235 |
| 110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17288680 |
| 111 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16443296 |
| 112 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13883725 |
| 113 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.12910338 |
| 114 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09979770 |
| 115 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09979770 |
| 116 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.09277839 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09043435 |
| 118 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08512626 |
| 119 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.07717934 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06230904 |
| 121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05500093 |
| 122 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05132297 |
| 123 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04527957 |
| 124 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04222827 |
| 125 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.03376840 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03115724 |
| 127 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02654971 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02643169 |
| 129 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00861488 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00704299 |
| 131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99519607 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98733935 |
| 133 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98645325 |
| 134 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.98402148 |
| 135 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98257948 |
| 136 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97638308 |
| 137 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.97366102 |
| 138 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96557575 |
| 139 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95753346 |
| 140 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95676113 |
| 141 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95607846 |
| 142 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.95593944 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.94956554 |
| 144 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94880327 |
| 145 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94647215 |
| 146 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94602880 |
| 147 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94443470 |
| 148 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94379641 |
| 149 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91993288 |
| 150 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91677215 |
| 151 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90457649 |
| 152 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.89243346 |
| 153 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88912441 |
| 154 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87006233 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86322366 |
| 156 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.85167785 |
| 157 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.82352156 |
| 158 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82066656 |
| 159 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.80377969 |
| 160 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.80190733 |
| 161 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.79670383 |
| 162 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.78835288 |
| 163 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78724552 |
| 164 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77911158 |
| 165 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77823675 |
| 166 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.76899737 |
| 167 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.74150201 |
| 168 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.72484598 |
| 169 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72278150 |
| 170 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71577375 |
| 171 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70301724 |
| 172 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.70089825 |
| 173 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69907779 |
| 174 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.69634933 |
| 175 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68501668 |
| 176 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.67742493 |
| 177 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.67532499 |
| 178 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.66116913 |
| 179 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65578567 |
| 180 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65135687 |
| 181 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64872927 |
| 182 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.63864466 |
| 183 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.62224549 |
| 184 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.61647199 |
| 185 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.61469521 |
| 186 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61382996 |
| 187 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.61204183 |
| 188 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.60901505 |
| 189 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.60408581 |
| 190 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.60347998 |
| 191 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.59956776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.63947923 |
| 2 | MP0005360_urolithiasis | 6.09846289 |
| 3 | MP0005365_abnormal_bile_salt | 5.21899913 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.05029012 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.17217212 |
| 6 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.05553378 |
| 7 | MP0009840_abnormal_foam_cell | 3.01090438 |
| 8 | MP0003195_calcinosis | 2.96241133 |
| 9 | MP0003252_abnormal_bile_duct | 2.90268329 |
| 10 | MP0005332_abnormal_amino_acid | 2.87397242 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.79606244 |
| 12 | MP0002102_abnormal_ear_morphology | 2.69296465 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.66059462 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.37031491 |
| 15 | MP0003122_maternal_imprinting | 2.27160340 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.25072461 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.22953909 |
| 18 | MP0002938_white_spotting | 2.20991013 |
| 19 | MP0009697_abnormal_copulation | 2.15322443 |
| 20 | MP0003136_yellow_coat_color | 2.12722462 |
| 21 | MP0005083_abnormal_biliary_tract | 2.12052012 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 2.08773875 |
| 23 | MP0003868_abnormal_feces_composition | 2.08440505 |
| 24 | MP0001764_abnormal_homeostasis | 2.06290035 |
| 25 | MP0001984_abnormal_olfaction | 2.00429382 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.97134336 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.95127993 |
| 28 | MP0008877_abnormal_DNA_methylation | 1.93777219 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.91126214 |
| 30 | MP0002653_abnormal_ependyma_morphology | 1.87840504 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.85398100 |
| 32 | MP0003880_abnormal_central_pattern | 1.83753987 |
| 33 | MP0004043_abnormal_pH_regulation | 1.83716051 |
| 34 | MP0003186_abnormal_redox_activity | 1.83493618 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.83414763 |
| 36 | MP0000631_abnormal_neuroendocrine_gland | 1.77855709 |
| 37 | * MP0000609_abnormal_liver_physiology | 1.76689305 |
| 38 | MP0005253_abnormal_eye_physiology | 1.71232903 |
| 39 | MP0004133_heterotaxia | 1.69346678 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.68272375 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.68090264 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.67912349 |
| 43 | MP0004885_abnormal_endolymph | 1.63045129 |
| 44 | MP0001293_anophthalmia | 1.62105196 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.60527078 |
| 46 | MP0002736_abnormal_nociception_after | 1.60225315 |
| 47 | MP0003011_delayed_dark_adaptation | 1.59619675 |
| 48 | MP0003890_abnormal_embryonic-extraembry | 1.59179720 |
| 49 | MP0001529_abnormal_vocalization | 1.56133992 |
| 50 | MP0001486_abnormal_startle_reflex | 1.56034213 |
| 51 | MP0002234_abnormal_pharynx_morphology | 1.53523520 |
| 52 | MP0003121_genomic_imprinting | 1.52952833 |
| 53 | MP0009745_abnormal_behavioral_response | 1.47770685 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.47714539 |
| 55 | MP0000778_abnormal_nervous_system | 1.47227960 |
| 56 | MP0004142_abnormal_muscle_tone | 1.46746708 |
| 57 | MP0005670_abnormal_white_adipose | 1.46320515 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.43390527 |
| 59 | MP0010030_abnormal_orbit_morphology | 1.39933036 |
| 60 | MP0003787_abnormal_imprinting | 1.39741994 |
| 61 | MP0009046_muscle_twitch | 1.37115516 |
| 62 | MP0008995_early_reproductive_senescence | 1.36739362 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.36435273 |
| 64 | MP0004036_abnormal_muscle_relaxation | 1.33192365 |
| 65 | MP0003567_abnormal_fetal_cardiomyocyte | 1.32153530 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 1.31972031 |
| 67 | MP0003878_abnormal_ear_physiology | 1.31972031 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.31698810 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.30376378 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 1.28807769 |
| 71 | MP0002272_abnormal_nervous_system | 1.27654278 |
| 72 | MP0000566_synostosis | 1.27200012 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.25563038 |
| 74 | MP0002078_abnormal_glucose_homeostasis | 1.24372224 |
| 75 | MP0005187_abnormal_penis_morphology | 1.23358110 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 1.22606774 |
| 77 | MP0004742_abnormal_vestibular_system | 1.22554104 |
| 78 | MP0003119_abnormal_digestive_system | 1.21739677 |
| 79 | MP0008872_abnormal_physiological_respon | 1.16524258 |
| 80 | MP0000427_abnormal_hair_cycle | 1.16377424 |
| 81 | MP0003718_maternal_effect | 1.16011725 |
| 82 | MP0000569_abnormal_digit_pigmentation | 1.15524600 |
| 83 | MP0000647_abnormal_sebaceous_gland | 1.13600527 |
| 84 | MP0005266_abnormal_metabolism | 1.11708530 |
| 85 | MP0005195_abnormal_posterior_eye | 1.11076996 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 1.11063442 |
| 87 | MP0001756_abnormal_urination | 1.10795781 |
| 88 | MP0002160_abnormal_reproductive_system | 1.10416627 |
| 89 | MP0003137_abnormal_impulse_conducting | 1.10414305 |
| 90 | MP0003656_abnormal_erythrocyte_physiolo | 1.10370263 |
| 91 | MP0000598_abnormal_liver_morphology | 1.08799333 |
| 92 | MP0000049_abnormal_middle_ear | 1.08504881 |
| 93 | MP0002876_abnormal_thyroid_physiology | 1.07746969 |
| 94 | MP0002572_abnormal_emotion/affect_behav | 1.07527976 |
| 95 | MP0005645_abnormal_hypothalamus_physiol | 1.07176773 |
| 96 | MP0000026_abnormal_inner_ear | 1.06660676 |
| 97 | MP0000749_muscle_degeneration | 1.05490110 |
| 98 | MP0000372_irregular_coat_pigmentation | 1.04622744 |
| 99 | MP0003283_abnormal_digestive_organ | 1.03934545 |
| 100 | MP0000230_abnormal_systemic_arterial | 1.03311232 |
| 101 | MP0002064_seizures | 1.01881344 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 1.01020148 |
| 103 | MP0005391_vision/eye_phenotype | 1.00908996 |
| 104 | MP0002233_abnormal_nose_morphology | 1.00665948 |
| 105 | MP0002254_reproductive_system_inflammat | 1.00563075 |
| 106 | MP0005386_behavior/neurological_phenoty | 1.00526300 |
| 107 | MP0004924_abnormal_behavior | 1.00526300 |
| 108 | MP0005330_cardiomyopathy | 0.99634303 |
| 109 | MP0008789_abnormal_olfactory_epithelium | 0.99573730 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.99397904 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.99226758 |
| 112 | MP0008469_abnormal_protein_level | 0.99082487 |
| 113 | MP0003938_abnormal_ear_development | 0.97996251 |
| 114 | MP0004130_abnormal_muscle_cell | 0.96389002 |
| 115 | MP0002751_abnormal_autonomic_nervous | 0.96201419 |
| 116 | MP0001286_abnormal_eye_development | 0.95637767 |
| 117 | MP0001324_abnormal_eye_pigmentation | 0.95459872 |
| 118 | MP0002752_abnormal_somatic_nervous | 0.95352465 |
| 119 | MP0005379_endocrine/exocrine_gland_phen | 0.95167406 |
| 120 | MP0004147_increased_porphyrin_level | 0.94571958 |
| 121 | MP0002067_abnormal_sensory_capabilities | 0.93720602 |
| 122 | MP0001661_extended_life_span | 0.91283889 |
| 123 | MP0001501_abnormal_sleep_pattern | 0.91188329 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.91130525 |
| 125 | MP0003724_increased_susceptibility_to | 0.90804263 |
| 126 | MP0010368_abnormal_lymphatic_system | 0.90377985 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.90364159 |
| 128 | MP0005423_abnormal_somatic_nervous | 0.89438255 |
| 129 | MP0002735_abnormal_chemical_nociception | 0.89141906 |
| 130 | MP0005389_reproductive_system_phenotype | 0.88249357 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.88016472 |
| 132 | MP0002269_muscular_atrophy | 0.87644236 |
| 133 | MP0005535_abnormal_body_temperature | 0.86380713 |
| 134 | MP0009763_increased_sensitivity_to | 0.84278712 |
| 135 | MP0002063_abnormal_learning/memory/cond | 0.83718567 |
| 136 | MP0002184_abnormal_innervation | 0.83408558 |
| 137 | MP0003635_abnormal_synaptic_transmissio | 0.82290850 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.82178674 |
| 139 | MP0001986_abnormal_taste_sensitivity | 0.80317716 |
| 140 | MP0005551_abnormal_eye_electrophysiolog | 0.78663702 |
| 141 | MP0003646_muscle_fatigue | 0.77755805 |
| 142 | MP0003183_abnormal_peptide_metabolism | 0.76943084 |
| 143 | MP0005408_hypopigmentation | 0.76114578 |
| 144 | MP0004264_abnormal_extraembryonic_tissu | 0.74931695 |
| 145 | MP0001765_abnormal_ion_homeostasis | 0.74031054 |
| 146 | MP0002638_abnormal_pupillary_reflex | 0.72812470 |
| 147 | MP0005451_abnormal_body_composition | 0.71910598 |
| 148 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70623386 |
| 149 | MP0000639_abnormal_adrenal_gland | 0.70335412 |
| 150 | MP0003953_abnormal_hormone_level | 0.69781450 |
| 151 | MP0009764_decreased_sensitivity_to | 0.69769826 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.65628571 |
| 153 | MP0000013_abnormal_adipose_tissue | 0.63369375 |
| 154 | MP0005647_abnormal_sex_gland | 0.63025623 |
| 155 | MP0002127_abnormal_cardiovascular_syste | 0.61895623 |
| 156 | MP0009765_abnormal_xenobiotic_induced | 0.61371194 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.60538482 |
| 158 | MP0000747_muscle_weakness | 0.59061522 |
| 159 | MP0002928_abnormal_bile_duct | 0.58002801 |
| 160 | MP0005334_abnormal_fat_pad | 0.57399474 |
| 161 | MP0002972_abnormal_cardiac_muscle | 0.55035425 |
| 162 | MP0002909_abnormal_adrenal_gland | 0.54981301 |
| 163 | MP0004145_abnormal_muscle_electrophysio | 0.54959382 |
| 164 | MP0005385_cardiovascular_system_phenoty | 0.54414153 |
| 165 | MP0001544_abnormal_cardiovascular_syste | 0.54414153 |
| 166 | MP0005620_abnormal_muscle_contractility | 0.53100460 |
| 167 | MP0003638_abnormal_response/metabolism_ | 0.52952906 |
| 168 | MP0001853_heart_inflammation | 0.52928655 |
| 169 | MP0002090_abnormal_vision | 0.52352462 |
| 170 | MP0006072_abnormal_retinal_apoptosis | 0.52079993 |
| 171 | MP0008873_increased_physiological_sensi | 0.52032911 |
| 172 | MP0005448_abnormal_energy_balance | 0.51884181 |
| 173 | MP0008775_abnormal_heart_ventricle | 0.51773484 |
| 174 | MP0002971_abnormal_brown_adipose | 0.50726828 |
| 175 | MP0003690_abnormal_glial_cell | 0.50527421 |
| 176 | MP0003950_abnormal_plasma_membrane | 0.48995141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.48696055 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.95762924 |
| 3 | Hypoglycemic coma (HP:0001325) | 4.87281323 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.67073144 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 4.35749910 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.33300628 |
| 7 | Ketosis (HP:0001946) | 4.23115402 |
| 8 | Xanthomatosis (HP:0000991) | 4.13562360 |
| 9 | Ketoacidosis (HP:0001993) | 3.99099255 |
| 10 | Hyperammonemia (HP:0001987) | 3.98200864 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.95280678 |
| 12 | Pancreatic cysts (HP:0001737) | 3.92272600 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.88550513 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.86849207 |
| 15 | True hermaphroditism (HP:0010459) | 3.86300803 |
| 16 | Abnormality of midbrain morphology (HP:0002418) | 3.84817992 |
| 17 | Molar tooth sign on MRI (HP:0002419) | 3.84817992 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.83433355 |
| 19 | Pancreatic fibrosis (HP:0100732) | 3.69200113 |
| 20 | Hypoglycemic seizures (HP:0002173) | 3.68868321 |
| 21 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.57891829 |
| 22 | Nephronophthisis (HP:0000090) | 3.55090612 |
| 23 | Dicarboxylic aciduria (HP:0003215) | 3.49333021 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.49333021 |
| 25 | Hepatic necrosis (HP:0002605) | 3.42543532 |
| 26 | Hyperglycinuria (HP:0003108) | 3.41298685 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.32149721 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.32149721 |
| 29 | Hyperglycinemia (HP:0002154) | 3.28275718 |
| 30 | Cerebral edema (HP:0002181) | 3.27153697 |
| 31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.26669364 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22761697 |
| 33 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.20898879 |
| 34 | Hypolipoproteinemia (HP:0010981) | 3.20107090 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 3.13990832 |
| 36 | Late onset (HP:0003584) | 3.13986210 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.13741586 |
| 38 | Symptomatic seizures (HP:0011145) | 3.05378687 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 3.04175569 |
| 40 | Joint hemorrhage (HP:0005261) | 3.02631468 |
| 41 | Fat malabsorption (HP:0002630) | 3.02476382 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.00068746 |
| 43 | Lethargy (HP:0001254) | 2.98965193 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.97886794 |
| 45 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.97031683 |
| 46 | Abnormality of alanine metabolism (HP:0010916) | 2.96122786 |
| 47 | Hyperalaninemia (HP:0003348) | 2.96122786 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.96122786 |
| 49 | Acute encephalopathy (HP:0006846) | 2.95814882 |
| 50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.95091235 |
| 51 | Type II lissencephaly (HP:0007260) | 2.94835033 |
| 52 | Metabolic acidosis (HP:0001942) | 2.93184817 |
| 53 | Conjugated hyperbilirubinemia (HP:0002908) | 2.91692391 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.91442197 |
| 55 | Medial flaring of the eyebrow (HP:0010747) | 2.90726215 |
| 56 | Glycosuria (HP:0003076) | 2.82430363 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.82430363 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.82103561 |
| 59 | Abnormality of the renal cortex (HP:0011035) | 2.80261109 |
| 60 | Hepatocellular necrosis (HP:0001404) | 2.77330457 |
| 61 | Hyperventilation (HP:0002883) | 2.72856072 |
| 62 | Gout (HP:0001997) | 2.71442402 |
| 63 | Complement deficiency (HP:0004431) | 2.70594092 |
| 64 | Myoglobinuria (HP:0002913) | 2.69764234 |
| 65 | Hypoalphalipoproteinemia (HP:0003233) | 2.66690303 |
| 66 | Chronic hepatic failure (HP:0100626) | 2.66632427 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.66244624 |
| 68 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.61228174 |
| 69 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.60859714 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.57732968 |
| 71 | Concave nail (HP:0001598) | 2.54620094 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.52416926 |
| 73 | Male pseudohermaphroditism (HP:0000037) | 2.52221478 |
| 74 | Epidermoid cyst (HP:0200040) | 2.51241988 |
| 75 | Acute necrotizing encephalopathy (HP:0006965) | 2.50808837 |
| 76 | Increased muscle lipid content (HP:0009058) | 2.49036797 |
| 77 | Colon cancer (HP:0003003) | 2.48819787 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.48195532 |
| 79 | Decreased circulating renin level (HP:0003351) | 2.47018488 |
| 80 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.45030366 |
| 81 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.45030366 |
| 82 | Mitochondrial inheritance (HP:0001427) | 2.44989672 |
| 83 | Abnormality of the labia minora (HP:0012880) | 2.44196670 |
| 84 | Cystic liver disease (HP:0006706) | 2.43638689 |
| 85 | Tubular atrophy (HP:0000092) | 2.43334594 |
| 86 | Hypercholesterolemia (HP:0003124) | 2.42523506 |
| 87 | Birth length less than 3rd percentile (HP:0003561) | 2.41364055 |
| 88 | Palpitations (HP:0001962) | 2.40432996 |
| 89 | Vomiting (HP:0002013) | 2.38006212 |
| 90 | Gait imbalance (HP:0002141) | 2.37910417 |
| 91 | Genital tract atresia (HP:0001827) | 2.37490899 |
| 92 | Inability to walk (HP:0002540) | 2.36565447 |
| 93 | Vaginal atresia (HP:0000148) | 2.34609794 |
| 94 | Increased CSF lactate (HP:0002490) | 2.32930822 |
| 95 | Congenital primary aphakia (HP:0007707) | 2.32716907 |
| 96 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.32681550 |
| 97 | Lactic acidosis (HP:0003128) | 2.31975315 |
| 98 | Lipid accumulation in hepatocytes (HP:0006561) | 2.31551831 |
| 99 | Abnormal biliary tract physiology (HP:0012439) | 2.30817074 |
| 100 | Bile duct proliferation (HP:0001408) | 2.30817074 |
| 101 | Pendular nystagmus (HP:0012043) | 2.29647076 |
| 102 | Steatorrhea (HP:0002570) | 2.28315923 |
| 103 | Anophthalmia (HP:0000528) | 2.24884574 |
| 104 | Sclerocornea (HP:0000647) | 2.24474136 |
| 105 | Irritability (HP:0000737) | 2.24473019 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 2.24443434 |
| 107 | Renal salt wasting (HP:0000127) | 2.22009401 |
| 108 | Abolished electroretinogram (ERG) (HP:0000550) | 2.20437234 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 2.18338421 |
| 110 | Septo-optic dysplasia (HP:0100842) | 2.18174084 |
| 111 | Patellar aplasia (HP:0006443) | 2.17922409 |
| 112 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17886603 |
| 113 | Renal Fanconi syndrome (HP:0001994) | 2.17749659 |
| 114 | Attenuation of retinal blood vessels (HP:0007843) | 2.16895195 |
| 115 | Cerebral palsy (HP:0100021) | 2.15754035 |
| 116 | Rhabdomyolysis (HP:0003201) | 2.14331247 |
| 117 | Skin nodule (HP:0200036) | 2.13900416 |
| 118 | Hyperphosphaturia (HP:0003109) | 2.13733169 |
| 119 | Methylmalonic aciduria (HP:0012120) | 2.13185892 |
| 120 | Opisthotonus (HP:0002179) | 2.12445762 |
| 121 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12006999 |
| 122 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12006999 |
| 123 | Anencephaly (HP:0002323) | 2.11172374 |
| 124 | Optic nerve hypoplasia (HP:0000609) | 2.10603295 |
| 125 | Alkalosis (HP:0001948) | 2.09862383 |
| 126 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.09441471 |
| 127 | Lissencephaly (HP:0001339) | 2.09014541 |
| 128 | Supernumerary spleens (HP:0009799) | 2.08720180 |
| 129 | Brushfield spots (HP:0001088) | 2.08299895 |
| 130 | Renal cortical cysts (HP:0000803) | 2.08128637 |
| 131 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.07590016 |
| 132 | Abnormality of glycolysis (HP:0004366) | 2.07485406 |
| 133 | Increased serum pyruvate (HP:0003542) | 2.07485406 |
| 134 | Cerebellar dysplasia (HP:0007033) | 2.07338164 |
| 135 | Progressive macrocephaly (HP:0004481) | 2.04440114 |
| 136 | Enlarged kidneys (HP:0000105) | 2.04438473 |
| 137 | Congenital hepatic fibrosis (HP:0002612) | 2.03521942 |
| 138 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.02790954 |
| 139 | Large for gestational age (HP:0001520) | 2.01893473 |
| 140 | Intestinal atresia (HP:0011100) | 2.01196161 |
| 141 | Hyperglycemia (HP:0003074) | 2.00983958 |
| 142 | Pancreatitis (HP:0001733) | 2.00096380 |
| 143 | Nausea (HP:0002018) | 1.98878019 |
| 144 | Increased serum lactate (HP:0002151) | 1.93647821 |
| 145 | Bilateral microphthalmos (HP:0007633) | 1.93456395 |
| 146 | Abnormal gallbladder morphology (HP:0012437) | 1.93090989 |
| 147 | Reduced antithrombin III activity (HP:0001976) | 1.92704188 |
| 148 | Dandy-Walker malformation (HP:0001305) | 1.91741026 |
| 149 | Postaxial foot polydactyly (HP:0001830) | 1.91331059 |
| 150 | CNS demyelination (HP:0007305) | 1.90847239 |
| 151 | Methylmalonic acidemia (HP:0002912) | 1.89884452 |
| 152 | Hepatocellular carcinoma (HP:0001402) | 1.89438063 |
| 153 | Arthropathy (HP:0003040) | 1.88919092 |
| 154 | Elevated hepatic transaminases (HP:0002910) | 1.88414589 |
| 155 | Keratoconus (HP:0000563) | 1.87361834 |
| 156 | Increased corneal curvature (HP:0100692) | 1.87361834 |
| 157 | Broad-based gait (HP:0002136) | 1.86780829 |
| 158 | Abnormal drinking behavior (HP:0030082) | 1.86726267 |
| 159 | Polydipsia (HP:0001959) | 1.86726267 |
| 160 | Partial agenesis of the corpus callosum (HP:0001338) | 1.86482171 |
| 161 | Hyperaldosteronism (HP:0000859) | 1.86351143 |
| 162 | Postaxial hand polydactyly (HP:0001162) | 1.84912665 |
| 163 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.83695967 |
| 164 | Abnormality of the pons (HP:0007361) | 1.83309087 |
| 165 | Cholelithiasis (HP:0001081) | 1.82293856 |
| 166 | Scrotal hypoplasia (HP:0000046) | 1.82030096 |
| 167 | Abnormality of vitamin metabolism (HP:0100508) | 1.81525682 |
| 168 | Furrowed tongue (HP:0000221) | 1.80240843 |
| 169 | Abnormality of the ileum (HP:0001549) | 1.80090209 |
| 170 | Poor coordination (HP:0002370) | 1.79404476 |
| 171 | Congenital, generalized hypertrichosis (HP:0004540) | 1.78734009 |
| 172 | Decreased central vision (HP:0007663) | 1.77507031 |
| 173 | Chorioretinal atrophy (HP:0000533) | 1.77364991 |
| 174 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.77102754 |
| 175 | Enlarged penis (HP:0000040) | 1.75678345 |
| 176 | Absent/shortened dynein arms (HP:0200106) | 1.75044816 |
| 177 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.75044816 |
| 178 | Occipital encephalocele (HP:0002085) | 1.74377915 |
| 179 | Progressive inability to walk (HP:0002505) | 1.73660767 |
| 180 | Meckel diverticulum (HP:0002245) | 1.72457785 |
| 181 | Hypoplasia of the pons (HP:0012110) | 1.71956940 |
| 182 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.71286848 |
| 183 | Focal motor seizures (HP:0011153) | 1.71131041 |
| 184 | Preaxial hand polydactyly (HP:0001177) | 1.67175388 |
| 185 | Severe muscular hypotonia (HP:0006829) | 1.66734228 |
| 186 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.66246762 |
| 187 | Gaze-evoked nystagmus (HP:0000640) | 1.65811409 |
| 188 | Hypoplasia of the uterus (HP:0000013) | 1.64786495 |
| 189 | Drooling (HP:0002307) | 1.64763290 |
| 190 | Pachygyria (HP:0001302) | 1.63632732 |
| 191 | Polyuria (HP:0000103) | 1.63356808 |
| 192 | Oligodactyly (hands) (HP:0001180) | 1.61398022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.38867057 |
| 2 | STK16 | 3.75166841 |
| 3 | FLT3 | 3.43863395 |
| 4 | INSRR | 3.18514745 |
| 5 | TIE1 | 2.94081260 |
| 6 | ZAK | 2.84318600 |
| 7 | ERN1 | 2.82916285 |
| 8 | TAOK3 | 2.47518223 |
| 9 | MAP4K2 | 2.43676690 |
| 10 | CASK | 2.41882005 |
| 11 | PIK3CG | 2.37522698 |
| 12 | NUAK1 | 2.24524085 |
| 13 | OBSCN | 2.24025906 |
| 14 | MKNK2 | 2.10608706 |
| 15 | MAPK15 | 2.09619367 |
| 16 | PASK | 2.03598246 |
| 17 | MYLK | 1.95308630 |
| 18 | FRK | 1.77399524 |
| 19 | MAP3K4 | 1.69924306 |
| 20 | FGFR4 | 1.69341805 |
| 21 | TEC | 1.67490733 |
| 22 | TLK1 | 1.64223945 |
| 23 | KDR | 1.59045265 |
| 24 | TGFBR1 | 1.56946097 |
| 25 | MAPK13 | 1.54807495 |
| 26 | MAP2K3 | 1.54564882 |
| 27 | PNCK | 1.53768084 |
| 28 | MKNK1 | 1.53559422 |
| 29 | EIF2AK3 | 1.50355746 |
| 30 | PINK1 | 1.46847537 |
| 31 | BRSK2 | 1.46660508 |
| 32 | DYRK2 | 1.45973637 |
| 33 | EPHA4 | 1.43780769 |
| 34 | WNK3 | 1.40802052 |
| 35 | MAP2K6 | 1.37864855 |
| 36 | NME2 | 1.36206880 |
| 37 | KIT | 1.36046371 |
| 38 | FGFR2 | 1.35053197 |
| 39 | MARK1 | 1.33444020 |
| 40 | PLK4 | 1.31176787 |
| 41 | WNK4 | 1.28432781 |
| 42 | BTK | 1.26919584 |
| 43 | PHKG1 | 1.22341171 |
| 44 | PHKG2 | 1.22341171 |
| 45 | TAF1 | 1.20366035 |
| 46 | PLK3 | 1.19526028 |
| 47 | STK38L | 1.19119658 |
| 48 | NEK1 | 1.18374019 |
| 49 | OXSR1 | 1.16772356 |
| 50 | PRKCG | 1.15008062 |
| 51 | NEK2 | 1.12409498 |
| 52 | PRKAA2 | 1.10565434 |
| 53 | PRKG2 | 1.06650351 |
| 54 | TRIM28 | 1.06483155 |
| 55 | STK39 | 1.05736518 |
| 56 | MAPK11 | 1.05542423 |
| 57 | BCR | 1.04710251 |
| 58 | PKN2 | 1.02934289 |
| 59 | VRK2 | 1.01544828 |
| 60 | NTRK2 | 1.00501847 |
| 61 | TYK2 | 0.99468117 |
| 62 | ADRBK1 | 0.99136257 |
| 63 | ZAP70 | 0.98887943 |
| 64 | PDK4 | 0.96968576 |
| 65 | PDK3 | 0.96968576 |
| 66 | AKT3 | 0.96270437 |
| 67 | NTRK3 | 0.96131530 |
| 68 | ACVR1B | 0.93907339 |
| 69 | MAP2K7 | 0.92191812 |
| 70 | IRAK3 | 0.91949677 |
| 71 | PLK2 | 0.91802820 |
| 72 | CSNK1G2 | 0.88526706 |
| 73 | BMPR1B | 0.88195249 |
| 74 | MUSK | 0.87409245 |
| 75 | CAMKK2 | 0.85625584 |
| 76 | TAOK2 | 0.85403589 |
| 77 | TGFBR2 | 0.84877851 |
| 78 | LMTK2 | 0.84123053 |
| 79 | CSNK1G1 | 0.83150560 |
| 80 | PRKCE | 0.82982689 |
| 81 | SIK1 | 0.82315805 |
| 82 | STK3 | 0.77290730 |
| 83 | NEK9 | 0.77172907 |
| 84 | HIPK2 | 0.75456440 |
| 85 | DAPK2 | 0.73539598 |
| 86 | TBK1 | 0.72220212 |
| 87 | VRK1 | 0.70920856 |
| 88 | ITK | 0.70899496 |
| 89 | PRKAA1 | 0.69670075 |
| 90 | MAP2K2 | 0.68709443 |
| 91 | IRAK4 | 0.67216437 |
| 92 | MAP3K3 | 0.67108778 |
| 93 | LATS1 | 0.66569841 |
| 94 | IRAK1 | 0.65916775 |
| 95 | MAP3K11 | 0.65466904 |
| 96 | PLK1 | 0.64906398 |
| 97 | JAK3 | 0.64390592 |
| 98 | CDC7 | 0.63889044 |
| 99 | CSNK1G3 | 0.62616117 |
| 100 | CAMK2A | 0.60542322 |
| 101 | STK11 | 0.60344651 |
| 102 | GRK1 | 0.60011472 |
| 103 | CDK8 | 0.58731001 |
| 104 | EIF2AK1 | 0.58609110 |
| 105 | NLK | 0.58293854 |
| 106 | ADRBK2 | 0.57816111 |
| 107 | PDK2 | 0.57751756 |
| 108 | PIK3CA | 0.57495498 |
| 109 | PKN1 | 0.55199990 |
| 110 | NME1 | 0.54464191 |
| 111 | MAP4K1 | 0.53344621 |
| 112 | CSF1R | 0.53066134 |
| 113 | MAP3K1 | 0.52531720 |
| 114 | DYRK3 | 0.52282651 |
| 115 | CSNK1A1L | 0.51226939 |
| 116 | ABL2 | 0.51139500 |
| 117 | CAMK2G | 0.50558072 |
| 118 | MAPK4 | 0.50484517 |
| 119 | IRAK2 | 0.49937687 |
| 120 | TTK | 0.49840837 |
| 121 | MAPKAPK5 | 0.49776829 |
| 122 | MATK | 0.49317807 |
| 123 | JAK2 | 0.48434226 |
| 124 | DYRK1A | 0.47937015 |
| 125 | CDK3 | 0.47390800 |
| 126 | PRKACG | 0.46785579 |
| 127 | BRAF | 0.46632594 |
| 128 | CAMK1 | 0.45936260 |
| 129 | MAP3K12 | 0.45520519 |
| 130 | EPHA3 | 0.44788007 |
| 131 | PAK3 | 0.44547043 |
| 132 | PTK6 | 0.44349813 |
| 133 | ERBB3 | 0.43504240 |
| 134 | CSNK1D | 0.42265095 |
| 135 | CAMK2D | 0.41917207 |
| 136 | BUB1 | 0.41774233 |
| 137 | EPHB2 | 0.41693870 |
| 138 | CSNK1A1 | 0.41484177 |
| 139 | DYRK1B | 0.41025636 |
| 140 | GRK7 | 0.39585636 |
| 141 | FGFR1 | 0.37789860 |
| 142 | MAPK12 | 0.37772802 |
| 143 | PRKG1 | 0.37714693 |
| 144 | ATR | 0.37645308 |
| 145 | CSNK1E | 0.37403369 |
| 146 | MAP2K4 | 0.37131308 |
| 147 | TNIK | 0.37083242 |
| 148 | RPS6KA5 | 0.36939187 |
| 149 | MET | 0.34901957 |
| 150 | PBK | 0.34383374 |
| 151 | PRKACA | 0.34382013 |
| 152 | TSSK6 | 0.34083727 |
| 153 | PRKCZ | 0.33863399 |
| 154 | IGF1R | 0.33505969 |
| 155 | EPHB1 | 0.33478477 |
| 156 | ATM | 0.33360138 |
| 157 | CCNB1 | 0.33189063 |
| 158 | ERBB2 | 0.32899944 |
| 159 | WEE1 | 0.32160051 |
| 160 | RPS6KA6 | 0.32033660 |
| 161 | SYK | 0.31556924 |
| 162 | PTK2B | 0.31097037 |
| 163 | TYRO3 | 0.29940612 |
| 164 | MINK1 | 0.29458935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22859940 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.80652875 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.76359205 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64870586 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52608579 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47467553 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45465621 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.43090194 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.42260593 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38054373 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37632512 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27200820 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.22420843 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.18804658 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.16294612 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14610267 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.14328470 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.07465073 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05647585 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 1.92191557 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90178669 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.88564950 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86188555 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.79748487 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.78585106 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.78472597 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74027903 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.72781554 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.68638598 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.63164275 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62724309 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.61120715 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.60626957 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60028911 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56530920 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56374975 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53992777 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53386267 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.49792234 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.47240507 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46086195 |
| 42 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.44197925 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42282793 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40600213 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.35977194 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35969890 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34693378 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33009586 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.30150730 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.26577963 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25082225 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22555415 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21704346 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19279540 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16201646 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15106536 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14579248 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12432672 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12288616 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11483360 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10179955 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06949013 |
| 63 | ABC transporters_Homo sapiens_hsa02010 | 1.06572597 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03225306 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 1.00269709 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.99695495 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99096785 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97249176 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97160722 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96625402 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 0.95157574 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.94050375 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92586194 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.89801505 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87272924 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86020223 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84915655 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.84547396 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83287852 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.80862375 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.78207665 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76970160 |
| 83 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76918646 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76533740 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75118682 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.73586209 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.72121319 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71037968 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68804452 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65556233 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61802684 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60549652 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.59773950 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59555686 |
| 95 | Insulin secretion_Homo sapiens_hsa04911 | 0.59215692 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.58598555 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56252460 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.52303247 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51639986 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49960225 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48566072 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46048598 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44845485 |
| 104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44262044 |
| 105 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42800913 |
| 106 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.41885207 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40824905 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.40655588 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40583887 |
| 110 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37332136 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35802107 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35240169 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33999796 |
| 114 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33453700 |
| 115 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31704727 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31425763 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28317244 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23935229 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.20185103 |
| 120 | Ribosome_Homo sapiens_hsa03010 | 0.19386514 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16845448 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.16796443 |
| 123 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.14940475 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12168401 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11717290 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.11673490 |
| 127 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09079717 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07817101 |
| 129 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.05818600 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.04025658 |

